Hype and high hopes
Article Abstract:
Issues are presented concerning the performance of biotechnology companies which have floated on the stock market. The fall in value of the shares of EpiTan from 20 Australian cents to 6 Australian cents per share is discussed.
Publication Name: Business Review Weekly
Subject: Business, general
ISSN: 0727-758X
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
Bird flu bonanza
Article Abstract:
Australian biotech companies, such as Biota Holdings, posted rise in share price. The increase is attributed to obtaining of marketing licenses on avian flu drugs.
Publication Name: Business Review Weekly
Subject: Business, general
ISSN: 0727-758X
Year: 2005
User Contributions:
Comment about this article or add new information about this topic:
Bad to worse
Article Abstract:
The reasons behind the fall of Australia's biotech stocks by 10.3%, for econd quarter 2005, are examined.
Publication Name: Business Review Weekly
Subject: Business, general
ISSN: 0727-758X
Year: 2005
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: High hopes. Minchin hoses down CEOs. RBA attracts interest in difficult period
- Abstracts: Singo and his Magic Millions. Got their Mojo working. Adland pitches a new line
- Abstracts: AAPT wired and wireless. Going to pieces. Telstra be damned - or privatised
- Abstracts: Marketing's best and brightest. Adland's new broom. Four online people-meters vie to survive
- Abstracts: The right stuff. Take time for the spiritual side